Grace Therapeutics GRCE
NASDAQ GRCE
$2.15 +0.04 (+1.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Shares Outstanding (Entity) (2017 - 2026)

Updated

Grace Therapeutics (GRCE) reported Shares Outstanding (Entity) of 16.27 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 17.7% from 13.83 million a year earlier and up 1.6% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Grace Therapeutics posted Shares Outstanding (Entity) of 16.02 million, up 16.8% from FY2025.

  • Shares Outstanding (Entity) has increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 45.3% (FY2021 to FY2026).
  • By fiscal year, Shares Outstanding (Entity) came in at 13.72 million in FY2025 (+45.9%), 9.4 million in FY2024 (+26.4%), 7.44 million in FY2023 (+21.1%) and 6.14 million in FY2022 (+148.5%).
  • The fiscal Q1 2027 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q4 2017.
  • Year over year, Shares Outstanding (Entity) has now increased in each of the last 26 quarters, with growth averaging 31.4% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.3% (fiscal Q1 2024) and 220.7% (fiscal Q3 2022) over the last five years.
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at 16.02 million (Q4 2026), 15.47 million (Q3 2026) and 14.13 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Grace Therapeutics 34.99 Mn 34.99 Mn - 16.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.27 Mn
Mar 31, 2026 16.02 Mn
Dec 31, 2025 15.47 Mn
Sep 30, 2025 14.13 Mn
Jun 30, 2025 13.83 Mn
Mar 31, 2025 13.72 Mn
Dec 31, 2024 10.14 Mn
Sep 30, 2024 10.14 Mn
Jun 30, 2024 10.14 Mn
Mar 31, 2024 9.40 Mn
Dec 31, 2023 9.40 Mn
Sep 30, 2023 7.55 Mn
Jun 30, 2023 7.44 Mn
Mar 31, 2023 7.44 Mn
Dec 31, 2022 7.44 Mn
Sep 30, 2022 7.44 Mn
Jun 30, 2022 7.42 Mn
Mar 31, 2022 6.14 Mn
Dec 31, 2021 7.38 Mn
Sep 30, 2021 5.46 Mn
API Access

Grace Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GRCE&period=max&api_key=YOUR_API_KEY